Elevated serum CRP levels after induction chemoradiotherapy reflect poor treatment response in association with IL-6 in serum and local tumor site in patients with advanced esophageal cancer.
Fujiwara
Hitoshi
H
Division of Digestive Surgery, Department of Surgery, Kyoto Prefectural University of Medicine, Kamigyo-ku, Kyoto, Japan. hfuji@koto.kpu-m.ac.jp
Suchi
Kentaro
K
Okamura
Shinichi
S
Okamura
Hiroko
H
Umehara
Seiji
S
Todo
Momoko
M
Shiozaki
Atsushi
A
Kubota
Takeshi
T
Ichikawa
Daisuke
D
Okamoto
Kazuma
K
Ochiai
Toshiya
T
Kokuba
Yukihito
Y
Sonoyama
Teruhisa
T
Otsuji
Eigo
E
D000368:Aged; D014408:Biomarkers, Tumor / Q000097:blood / Q000378:metabolism*; D002097:C-Reactive Protein / Q000378:metabolism*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology / Q000532:radiotherapy; D003131:Combined Modality Therapy / Q000379:methods; D018450:Disease Progression; D004938:Esophageal Neoplasms / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology / Q000532:radiotherapy; D005260:Female; D006801:Humans; D015850:Interleukin-6 / Q000097:blood / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D016896:Treatment Outcome
D014408:Biomarkers, Tumor; D015850:Interleukin-6; D002097:C-Reactive Protein